Cardiff Oncology Inc (CRDF) — Tangible Net Worth Ratio
Cardiff Oncology Inc (CRDF) has a Tangible Net Worth Ratio of 100.0% as of December 2025. This metric is calculated by deducting intangible assets ($0.00) from net assets ($45.39 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of Cardiff Oncology Inc to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Cardiff Oncology Inc Tangible Net Worth Ratio (2012–2025)
This chart shows how Cardiff Oncology Inc's Tangible Net Worth Ratio has changed across 14 annual periods from 2012 to 2025. As of December 2025, the ratio stands at 100.0%, reflecting net assets of $45.39 Million with intangible assets of $0.00 USD. For live market cap and overall valuation, see CRDF market cap.
Annual Tangible Net Worth Ratio for Cardiff Oncology Inc (2012–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Cardiff Oncology Inc from 2012 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See CRDF free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $45.39 Million | $0.00 | $61.88 Million | ▲ +0.0 pp |
| 2024 | 100.0% | $82.95 Million | $0.00 | $97.19 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $69.74 Million | $0.00 | $81.64 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $106.34 Million | $0.00 | $116.19 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $140.42 Million | $0.00 | $149.54 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $128.16 Million | $0.00 | $134.73 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $7.31 Million | $0.00 | $13.09 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $10.08 Million | $0.00 | $14.17 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $6.51 Million | $0.00 | $12.29 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $19.77 Million | $0.00 | $43.95 Million | ▲ +0.0 pp |
| 2015 | 100.0% | $48.70 Million | $0.00 | $71.45 Million | ▲ +0.0 pp |
| 2014 | 100.0% | $8.35 Million | $0.00 | $28.90 Million | ▲ +0.0 pp |
| 2013 | 100.0% | $20.39 Million | $0.00 | $27.16 Million | ▲ +0.0 pp |
| 2012 | 100.0% | $2.17 Million | $0.00 | $11.66 Million | — |